Skip to main content

Desogestrel: Review of Pharmacology and Clinical Trials

  • Conference paper
Female Contraception
  • 149 Accesses

Abstract

In recent years it has been increasingly realized that not only estrogens but also progestogens [4] can be responsible for a variety of both favorable and adverse side effects of oral contraceptives, and that their metabolic effects belong to the potentially serious ones. The fact that some untoward effects of progestogens seem to be structure-related encouraged chemical and pharmaceutical research to look for new substances with properties which might better meet medical requirements. As a result many new compounds were synthesized and three of the so- called new-generation progestogens have been subjected to extensive trials: norg- estimate (Ortho), gestoden (Schering) and desogestrel (Organon).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bettendorf G et al. (1987) Hormonelle Empfängnisverhütung. Dtsch Ärztezeitung 6, 57:23

    Google Scholar 

  2. Geißler KH (1983) Hormonelle Kontrazeption mit Marvelon, Erfahrungen mit Marvelon in der gynäkologischen Praxis—Multicenter-Studie bei 265 Gynäkologen und über 26000 Frauen. Fortschr Med 101:1060–1064

    PubMed  Google Scholar 

  3. Geißler KH (1986) Long term study of the effect on body weight and blood pressure of a desogestrel containing micropill. 12th World Congress on Fertility and Sterility, Singapore, Okt. 26–31.

    Google Scholar 

  4. Kopera H (1985) Unbeabsichtigte Wirkungen der oralen Kontrazeptiva. II. Progesta- gen-bedingte Effekte, Wechselwirkungen mit Arzneimitteln. Wien Med Wochenschr 135:415–419

    PubMed  CAS  Google Scholar 

  5. Kopera H (1986) Efectos metabolicos de los contraceptivos orales. Med Int 2, 2:76–92

    Google Scholar 

  6. Kopera H, Weijers MJ (1983) Desogestrel: a new progestogen. In: van Keep PA, Kopera H (eds) Oral contraceptives and lipoproteins. Workshop Conference in Hawaii, pp 64–84

    Google Scholar 

  7. Luyckx AS, Gaspard UJ, Romus MA, Grigorescu F, de Meyts P, Lefèbre PJ (1986) Carbohydrate metabolism in women who used oral contraceptives containing levonorgestrel or desogestrel: a 6-month prospective study. Fertil Steril 45:635–642

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Kopera, H. (1988). Desogestrel: Review of Pharmacology and Clinical Trials. In: Runnebaum, B., Rabe, T., Kiesel, L. (eds) Female Contraception. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73790-9_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-73790-9_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-73792-3

  • Online ISBN: 978-3-642-73790-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics